vs

Side-by-side financial comparison of MultiSensor AI Holdings, Inc. (MSAI) and Instil Bio, Inc. (TIL). Click either name above to swap in a different company.

Instil Bio, Inc. is the larger business by last-quarter revenue ($2.2M vs $1.4M, roughly 1.6× MultiSensor AI Holdings, Inc.). MultiSensor AI Holdings, Inc. runs the higher net margin — -164.1% vs -365.3%, a 201.2% gap on every dollar of revenue. On growth, MultiSensor AI Holdings, Inc. posted the faster year-over-year revenue change (-0.9% vs -19.2%).

Figure AI, Inc. is an American robotics company developing AI-powered humanoid robots. The company was founded in 2022 by Brett Adcock, also known for founding Archer Aviation and Vettery.

Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.

MSAI vs TIL — Head-to-Head

Bigger by revenue
TIL
TIL
1.6× larger
TIL
$2.2M
$1.4M
MSAI
Growing faster (revenue YoY)
MSAI
MSAI
+18.3% gap
MSAI
-0.9%
-19.2%
TIL
Higher net margin
MSAI
MSAI
201.2% more per $
MSAI
-164.1%
-365.3%
TIL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MSAI
MSAI
TIL
TIL
Revenue
$1.4M
$2.2M
Net Profit
$-2.3M
$-8.2M
Gross Margin
Operating Margin
-171.6%
-426.3%
Net Margin
-164.1%
-365.3%
Revenue YoY
-0.9%
-19.2%
Net Profit YoY
23.7%
31.1%
EPS (diluted)
$-0.02
$-1.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MSAI
MSAI
TIL
TIL
Q4 25
$1.4M
$2.2M
Q3 25
$1.6M
$2.2M
Q2 25
$1.4M
$2.2M
Q1 25
$1.2M
$2.2M
Q4 24
$1.4M
$2.8M
Q3 24
$1.6M
$1.5M
Q2 24
$2.1M
$0
Q1 24
$2.3M
$0
Net Profit
MSAI
MSAI
TIL
TIL
Q4 25
$-2.3M
$-8.2M
Q3 25
$-1.7M
$-13.6M
Q2 25
$-3.3M
$-21.4M
Q1 25
$-4.4M
$-28.2M
Q4 24
$-3.0M
$-11.9M
Q3 24
$-8.2M
$-23.0M
Q2 24
$-6.4M
$-14.9M
Q1 24
$-3.9M
$-24.3M
Operating Margin
MSAI
MSAI
TIL
TIL
Q4 25
-171.6%
-426.3%
Q3 25
-107.6%
-670.0%
Q2 25
-233.8%
-1045.5%
Q1 25
-394.6%
-1363.2%
Q4 24
-199.6%
-426.1%
Q3 24
-541.5%
-1582.8%
Q2 24
-228.1%
Q1 24
-112.7%
Net Margin
MSAI
MSAI
TIL
TIL
Q4 25
-164.1%
-365.3%
Q3 25
-106.5%
-606.0%
Q2 25
-234.1%
-954.2%
Q1 25
-379.1%
-1257.8%
Q4 24
-213.2%
-428.8%
Q3 24
-511.5%
-1541.9%
Q2 24
-300.8%
Q1 24
-172.4%
EPS (diluted)
MSAI
MSAI
TIL
TIL
Q4 25
$-0.02
$-1.13
Q3 25
$-0.05
$-2.01
Q2 25
$-0.10
$-3.24
Q1 25
$-0.14
$-4.32
Q4 24
$0.07
$-1.82
Q3 24
$-0.34
$-3.54
Q2 24
$-0.47
$-2.29
Q1 24
$-0.33
$-3.74

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MSAI
MSAI
TIL
TIL
Cash + ST InvestmentsLiquidity on hand
$24.4M
$6.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$32.0M
$113.9M
Total Assets
$35.5M
$203.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MSAI
MSAI
TIL
TIL
Q4 25
$24.4M
$6.6M
Q3 25
$1.1M
$5.8M
Q2 25
$3.2M
$7.7M
Q1 25
$4.7M
$15.4M
Q4 24
$4.4M
$8.8M
Q3 24
$8.6M
$6.7M
Q2 24
$234.0K
$6.8M
Q1 24
$491.0K
$5.5M
Total Debt
MSAI
MSAI
TIL
TIL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$642.0K
Q1 24
$2.8M
Stockholders' Equity
MSAI
MSAI
TIL
TIL
Q4 25
$32.0M
$113.9M
Q3 25
$8.3M
$120.4M
Q2 25
$9.8M
$131.7M
Q1 25
$12.9M
$144.9M
Q4 24
$12.3M
$169.4M
Q3 24
$15.6M
$176.3M
Q2 24
$1.6M
$195.0M
Q1 24
$1.4M
$205.8M
Total Assets
MSAI
MSAI
TIL
TIL
Q4 25
$35.5M
$203.5M
Q3 25
$11.9M
$211.8M
Q2 25
$14.6M
$231.0M
Q1 25
$16.4M
$237.4M
Q4 24
$15.5M
$263.6M
Q3 24
$18.9M
$272.6M
Q2 24
$16.4M
$294.3M
Q1 24
$14.1M
$306.3M
Debt / Equity
MSAI
MSAI
TIL
TIL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.41×
Q1 24
2.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MSAI
MSAI
TIL
TIL
Operating Cash FlowLast quarter
$-2.2M
$-7.1M
Free Cash FlowOCF − Capex
$-2.6M
FCF MarginFCF / Revenue
-187.3%
Capex IntensityCapex / Revenue
26.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-9.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MSAI
MSAI
TIL
TIL
Q4 25
$-2.2M
$-7.1M
Q3 25
$-1.8M
$-10.6M
Q2 25
$-804.0K
$-14.8M
Q1 25
$-3.2M
$-4.2M
Q4 24
$-3.1M
$-10.6M
Q3 24
$-12.7M
$-20.1M
Q2 24
$-303.0K
$-10.6M
Q1 24
$492.0K
$-14.4M
Free Cash Flow
MSAI
MSAI
TIL
TIL
Q4 25
$-2.6M
Q3 25
$-2.1M
Q2 25
$-1.3M
Q1 25
$-3.6M
Q4 24
$-4.1M
Q3 24
$-13.2M
Q2 24
$-844.0K
Q1 24
$-79.0K
FCF Margin
MSAI
MSAI
TIL
TIL
Q4 25
-187.3%
Q3 25
-136.1%
Q2 25
-91.5%
Q1 25
-308.6%
Q4 24
-294.6%
Q3 24
-823.2%
Q2 24
-39.7%
Q1 24
-3.5%
Capex Intensity
MSAI
MSAI
TIL
TIL
Q4 25
26.2%
Q3 25
21.5%
Q2 25
34.8%
Q1 25
37.2%
Q4 24
76.2%
0.0%
Q3 24
30.5%
0.0%
Q2 24
25.5%
Q1 24
25.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons